EcoDrugPlus

Protein Kinase C Iota

Ensembl ID : ENSBTAG00000001403
Gene Symbol: PRKCI
12 Enzyme and pathways 5 Cross references
238 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSBTAG00000010664
Gene Symbol: PRKCQ
26 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSBTAG00000014119
Gene Symbol: PRKCZ
16 Enzyme and pathways 5 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSBTAG00000012789
Gene Symbol: PRKD1
4 Enzyme and pathways 5 Cross references
226 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSBTAG00000001114
Gene Symbol: PRKD3
4 Enzyme and pathways 5 Cross references
286 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSBTAG00000006642
Gene Symbol: PRKACA
77 Enzyme and pathways 5 Cross references
300 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSBTAG00000011953
Gene Symbol: PRKACB
5 Cross references
316 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSBTAG00000017019
Gene Symbol: PRKDC
7 Enzyme and pathways 5 Cross references
199 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSBTAG00000016005
Gene Symbol: PPP3CA
15 Enzyme and pathways 5 Cross references
244 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSBTAG00000009578
Gene Symbol: PTK2
39 Enzyme and pathways 5 Cross references
244 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSBTAG00000005958
Gene Symbol: PTK2B
15 Enzyme and pathways 5 Cross references
225 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSBTAG00000044091
Gene Symbol: PTK6
23 Enzyme and pathways 5 Cross references
185 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).